Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersGynecologic Oncology Physician in Portland, OR
NPI: 1295716496Primary Practice Location
PROVIDENCE ST VINCENT MEDICAL CENTER
9205 Sw Barnes Rd, Portland, OR
Primary Employer
Compass Oncology
compassoncology.com
HQ Phone
Get M.D. William's Phone Numberphone_androidMobile
Get M.D. William's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOR State Medical License
WA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 41 | 112 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 32 | 49 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 28 | 28 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 26 | 58 |
| 5 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 21 | 100 |
Robotic surgical staging for obese patients with endometrial cancer.
Authors: Michael Sundborg, Erin Keyser, Beverly Reed, Edward Kost, Charles Leath
Journal: Am J Obstet Gynecol
Publication Date: 2011-05-10
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, RADIATION: External Beam Radiation Therapy, DRUG: Cisplatin, RADIATION: Radiation Therapy, RADIATION: Intensity-Modulated Radiation Therapy, DRUG: Triapine, RADIATION: Brachytherapy
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology, Canadian Cancer Trials Group
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, DRUG: Topotecan Hydrochloride, DRUG: Olaparib, DRUG: Paclitaxel, DRUG: Topotecan, PROCEDURE: Computed Tomography, DRUG: Pegylated Liposomal Doxorubicin Hydrochloride, DRUG: Cediranib, DRUG: Cediranib Maleate
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: AstraZeneca, NRG Oncology
Intervention / Treatment: DRUG: Carboplatin, PROCEDURE: Magnetic Resonance Imaging, OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, PROCEDURE: Biospecimen Collection, DRUG: Gemcitabine Hydrochloride, DRUG: Olaparib, OTHER: Quality-of-Life Assessment, DRUG: Gemcitabine, DRUG: Paclitaxel, PROCEDURE: Computed Tomography, PROCEDURE: Multigated Acquisition Scan, DRUG: Pegylated Liposomal Doxorubicin Hydrochloride, PROCEDURE: Echocardiography Test, DRUG: Cediranib Maleate
